Page last updated: 2024-11-13

gonyautoxin v

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gonyautoxin V: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID49789073
CHEMBL ID496271
CHEBI ID138870
MeSH IDM0124643

Synonyms (19)

Synonym
gonyautoxin v
CHEBI:138870
gonyautoxin 5
({[(3as,4r,10as)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3h,8h-pyrrolo[1,2-c]purin-4-yl]methoxy}carbonyl)sulfamic acid
64296-25-9
CHEMBL496271
gtx5
C20018
122139-78-0
gonyautoxin-v
carbamic acid, sulfo-, c-((2,6-diamino-3a,4,9,10-tetrahydro-10,10-dihydroxy-1h,8h-pyrrolo(1,2-c)purin-4-yl)methyl) ester, (3as-(3aalpha,4alpha,10ar*))-
3833h3turf ,
unii-3833h3turf
carbamic acid, sulfo-, c-(((3as,4r,10as)-2,6-diamino-3a,4,9,10-tetrahydro-10,10-dihydroxy-1h,8h-pyrrolo(1,2-c)purin-4-yl)methyl) ester
((3as,4r,10as)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-3h-pyrrolo(1,2-c)purin-4-yl)methoxycarbonylsulfamic acid
DTXSID60214520
gonyautoxin-5
Q27256732
[(3as,4r,10as)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxycarbonylsulfamic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
marine metaboliteAny metabolite produced during a metabolic reaction in marine macro- and microorganisms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organic heterotricyclic compoundAn organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms.
paralytic shellfish toxin
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID362645Toxicity in mouse at 160 MU/umol, ip2008Journal of natural products, Sep, Volume: 71, Issue:9
Isolation and structure elucidation of new and unusual saxitoxin analogues from mussels.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (42.86)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.72 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]